RE:RE:RE:RE:RE:News
Everything seems to be highly speculative with TST (except the BLA submission by March 31st). This stock has very high expectations of failure and collapse from its current shareholders for some reason. But my 2 cents is that the sellers might just have an interest in keeping the share price as low as possible and the company as far off the radar as can be. This has "cheap buyout" written all over it. There seems to be progress on the operations side but nothing at all is transpiring vis a vis shareholders. A 50-60 cent offer is not out the question. The company has no no momentum in its share price, no demand for a piece of its success, IR, no public face, no coverage etc. There is nothing to offset the perception of looming circling doom from the FDA. Maybe a 5 for 1 rollback and US is in the works.